Measuring the Market's Value
As the third quarter begins, we dig into the fair value of the Dow once again.
As the third quarter begins, we dig into the fair value of the Dow once again.
Morningstar has more than 100 equity analysts who estimate fair values for more than 2,000 stocks. Because we have such breadth of coverage, we can assess the valuation of major market indexes by calculating market-cap weighted averages of our fair value estimates for the stocks in the benchmarks. Then we can determine if the indexes are over or undervalued by comparing their aggregate fair values to their current market prices.
Every quarter, we do just that for the three major market indexes--the Dow, the S&P 500, and the Nasdaq 100. As of the end of the second quarter, it appears that the market, as measured by these benchmarks, is still trading right near our estimate of the fair value (see table below), as it was last quarter when we last updated this topic.
Still, there are a few corners of the market where some modest bargains are lurking. For example, cheap stocks have been more prevalent lately among wide-moat industry leaders. In aggregate, all of the wide-moat firms in Morningstar's coverage universe are currently trading at a 5% discount to fair value.
That's why it's not to surprising to see the Dow as the only broad market barometer that's trading below its fair value estimate. It's dominated by big blue-chip stocks, many of which look attractively valued at the moment.
Market Index Valuations | |||
Index Value | Fair Value Estimate | % Under- or Overvalued | |
Dow Jones Ind. Average | 13,408.62 | 14,204.32 | -5.9% |
S&P 500 | 1,503.35 | 1,501.02 | 0.2% |
Nasdaq 100 | 1,934.10 | 1,887.98 | 2.4% |
Data as of 06-29-07 |
Cheap Dow Components
At the end of the second quarter, 13 Dow components had 4-star or 5-star ratings. (Remember that, generally speaking, stocks trading at large discounts to our analysts' fair value estimates will receive higher, 4-star or 5-star Morningstar Ratings, and stocks trading at large premiums to our fair value estimates will receive lower, 1-star or 2-star ratings.)
Dow Components with Recent 4- or 5-Star Morningstar Ratings | |||||
Company | Fair Value Estimate | Market Price | Moat Rating | Risk Rating | Morningstar |
3M (MMM) | $103 | $86.79 | Wide | Below Average | |
Johnson & Johnson (JNJ) | $80 | $61.62 | Wide | Below Average | |
Pfizer (PFE) | $33 | $25.57 | Wide | Average | |
Wal-Mart (WMT) | $60 | $48.11 | Wide | Below Average | |
Procter & Gamble (PG) | $77 | $61.19 | Wide | Below Average | |
American Express (AXP) | $70 | $61.03 | Wide | Below Average | |
Coca-Cola (KO) | $60 | $52.31 | Wide | Below Average | |
Home Depot (HD) | $44 | $39.35 | Wide | Below Average | |
Microsoft (MSFT) | $34 | $29.47 | Wide | Average | |
American Int'l Group (AIG) | $80 | $70.03 | Narrow | Average | |
J.P. Morgan Chase (JPM) | $63 | $48.08 | Wide | Average | |
Citigroup (C) | $64 | $51.29 | Wide | Average | |
Walt Disney (DIS) | $40 | $34.14 | Wide | Below Average | |
Data as of June 29, 2007 |
The table looks largely the same as it did the last time we visited this topic, but there have been a few changes worth noting.
Specifically, United Technologies (UTX) and Alcoa both fell off the list during the second quarter after its Morningstar Rating went from 5 stars to 3 stars. Both stocks rallied strongly during the quarter and moved within range of our fair value estimates for the stocks.
A new face on the list is Procter & Gamble (PG), which moved from 3 stars to 5 stars over the course of the quarter. The move came about when stock analyst Lauren DeSanto raised her fair value estimate for the firm. DeSanto believes that the risk of P&G's integration of Gillette, which it acquired 18 months ago, is largely in the past. Moreover, she suspects that recent ho-hum quarterly results have caused some investors to lose sight of the firm's long-term strengths--its balanced portfolio of products and proven ability to create blockbuster brands. The stock lost 1.5% during the quarter, and DeSanto thinks that the recent sluggishness has created an opportunity to invest in a firm that has one of the widest moats around at a respectable margin of safety.
ETFs as Windows to Sector Valuations
The change in P&G's star rating had an impact on the fair values of consumer ETFs. Both Consumer Staples Select Sector SPDR (XLP) and Vanguard Consumer Staples ETF (VDC) are trading at attractive valuations at present. Because these ETFs are market-cap weighted, P&G takes up a lot of room in these ETFs and has a significant impact on their fair values.
Some health-care ETFs also are trading below their aggregate fair values. Consistent with our mega-cap theme, giant pharmaceutical firms represent some of the best values in that sector. As a result, market-cap-weighted health-care ETFs, like Healthcare Select Sector SPDR (XLV), iShares S&P Global Healthcare (IXJ), and Vanguard Healthcare ETF (VHT), look cheap.
Some financial ETFs appear undervalued as well. Again, the biggest names in the sector represent some of the best bargains. Big multinational banks, like JP Morgan Chase (JPM) and Bank of America (BAC),are trading well below our analysts' fair value estimates. Going a bit further down the capitalization ladder, super regional banks, such as BB&T (BBT) and US Bancorp (USB), also look undervalued. Moreover, some segments of the insurance industry are beginning to take on attractive valuation characteristics. As a result, some financial ETFs, such as iShares Dow Jones U.S. Financial Services Index (IYG) and PowerShares FTSE Financials look attractive from a valuation perspective.
On the flip side, ETFs that focus on oil and gas service firms, such as iShares Dow Jones US Oil Equipment Index (IEZ) and SPDR S&P Oil & Gas Equipment & Services (XES), are loaded with pricey stocks. Oil stocks have enjoyed a strong rally pretty much across the board, but the oil service sector seems particularly pricey. Big sector leaders like Schlumberger (SLB), Halliburton (HAL), and Transocean (RIG), are trading well above analysts' fair value estimates.
It's a similar story for steel and iron stocks, like AK Steel and Cleveland Cliffs (CLF), which have also enjoyed a strong rally this year that propelled them into overvalued territory. As a result, it's not surprising that Market Vectors Steel ETF looks expensive.
REIT stocks have stumbled recently. In fact, iShares Cohen & Steels Realty Majors ETF (ICF) lost almost 12% during the second quarter. Nevertheless, REITs ran so strong for so long that they remain squarely in overvalued range, which suggests that there could be more downside to come.
Finally, here's a table of price/fair value ratios for selected ETFs. A price/fair value ratio is simply the ETF's price divided by its collective fair value. A price/fair value ratio below 1.0 indicates that the ETF is undervalued, while a price/fair value ratio above 1.0 indicates that the ETF is overpriced.
Price/Fair Value Ratios for Selected ETFs | |
Price/ Fair Value | |
KBW Bank ETF (KBE) | 0.84 |
iShares Dow Jones US Financials (IYG) | 0.86 |
Consumer Staples Select Sector SPDR (XLP) | 0.89 |
Financial Select Sector SPDR (XLF) | 0.89 |
PowerShares FTSE RAFI Financials | 0.89 |
Vanguard Consumer Staples ETF (VDC) | 0.90 |
PowerShares FTSE RAFI Consumer Services | 0.90 |
Health Care Select SPDR (XLV) | 0.91 |
iShares Dow Jones US Consumer Services Sector Index (IYC) | 0.91 |
iShares Dow Jones US Financial Sector Index (IYF) | 0.91 |
iShares S&P Global Healthcare (IXJ) | 0.91 |
Vanguard Financials ETF (VFH) | 0.91 |
iShares Dow Jones US Consumer Goods Sector Idx Fund (IYK) | 0.92 |
Vanguard Health Care ETF (VHT) | 0.92 |
iShares Cohen & Steers Realty majors ETF (ICF) | 1.17 |
Market Vectors Steel | 1.22 |
SPDR S&P Oil & Gas Equipment & Services (XES) | 1.43 |
iShares Dow Jones US Oil Equipment Index (IEZ) | 1.69 |
Data as of June 29, 2007 |
Morningstar ETFInvestor, our monthly newsletter about the world of ETFs, provides data (including price/fair value ratios) and analysis of ETF fair values in every issue, including the best values of all the ETFs on our coverage list. To check it out, click here.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.